Tasigna

Tasigna Lawsuit News: Recent Studies Suggest Leukemia Drug May Increase Risk for Arteriosclerosis, Peripheral Artery Disease & Related Vascular Conditions

NEW YORK, NY — Tasigna lawsuits filed in recent months have highlighted a growing body of scientific evidence linking the leukemia drug to arteriosclerosis, peripheral artery disease, and related vascular conditions. For example, in 2011, the American Journal of Hematology published a study involving 24 patients who were taking Tasigna to treat chronic myelogenous leukemia … Continue reading Tasigna Lawsuit News: Recent Studies Suggest Leukemia Drug May Increase Risk for Arteriosclerosis, Peripheral Artery Disease & Related Vascular Conditions